IVIM Health vs TMates: Compounded GLP-1 options compared
Quick verdict: IVIM Health vs TMates
IVIM Health positions a clinician-guided program with dual 4.9-star ratings, a no-obligation $75 consultation, and both compounded semaglutide and tirzepatide options. TMates emphasizes a flat $199/month semaglutide plan with 24/7 U.S.-based doctor access and consistent pricing across doses. Early verdict: choose IVIM Health if you prioritize third-party ratings and multiple compound options; choose TMates if you value predictable flat pricing and round-the-clock physician availability.
Explore IVIM Health program details
What they offer: medications and formulation
Both providers supply compounded GLP-1 medications, not FDA-approved finished products. IVIM Health lists compounded semaglutide and compounded tirzepatide and notes medications are prepared by independent, licensed compounding pharmacies. TMates offers compounded semaglutide formulated in U.S.-based facilities; TMates’ public detail on tirzepatide availability is limited.
Pricing and membership differences
Pricing approaches diverge. IVIM advertises a promotional free month membership with code GIFT75, a no-obligation consultation valued at $75, and published prices showing semaglutide at $75/mo and tirzepatide at $133/mo in some captured landing details, plus a $74.99/mo program fee. TMates sells a flat $199/month rate that the company says stays the same at every dose with no step-up fees; their published multi-month bundles show per-month variations for different durations but TMates emphasizes a flat monthly model for budgeting.
Access, oversight, and availability
TMates highlights 24/7 access to U.S.-based doctors across all 50 states and virtual check-ins as part of its model. IVIM Health describes a clinician-guided protocol with weekly dose adjustments and clinician oversight, and notes prescriptions are provided after clinical evaluation. IVIM also cautions that compounded medications are not available in all states. TMates states it ships to most states and that availability is based on medical eligibility.
Evidence, ratings, and program claims
IVIM Health emphasizes dual 4.9-star ratings on Google and Trustpilot and references internal and published retrospective observational studies in Obesity Pillars that IVIM says support its clinical outcomes. IVIM presents a proprietary GLP-1 ID protocol that the company claims can accelerate weight loss by up to 40% compared to a cited clinical GLP-1 trial; IVIM notes this is its protocol claim and not a head-to-head randomized trial. TMates frames its program as clinically dosed compounded semaglutide and positions domestic formulation and physician availability as quality signals. Both providers include regulatory notes that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Side-by-side: IVIM Health vs TMates
| Criteria | IVIM Health | TMates |
|---|---|---|
| Primary medication options | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide (tirzepatide details limited) |
| Pricing model | Promotional free-month code GIFT75; sample pricing shows $75/mo semaglutide, $133/mo tirzepatide; $74.99 program fee noted | Flat $199/month at every dose; no step-up fees |
| Doctor access | Clinician-guided protocol with weekly dose adjustments and clinician evaluation | 24/7 U.S.-based doctor access and virtual check-ins |
| Third-party ratings / evidence | 4.9 stars on Google and Trustpilot; internal and published retrospective studies cited | Emphasizes U.S. formulation and clinician dosing; no dual third-party rating claim provided |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
How to weigh these differences
If independent third-party ratings and multiple compounded medication options matter, IVIM Health documents dual 4.9-star ratings and lists both semaglutide and tirzepatide in its offering. If predictable budgeting and continuous physician access are your priorities, TMates emphasizes a flat $199/month price that does not increase with dose and 24/7 U.S.-based doctor availability.
Review IVIM Health membership and study notes
Bottom line: IVIM Health vs TMates
Both IVIM Health and TMates provide clinician-reviewed, compounded GLP-1 care and both include regulatory disclaimers that compounded drugs are not FDA-approved. IVIM stands out for dual 4.9-star ratings, a no-obligation $75 consultation, a GIFT75 free-month promotion, and both semaglutide and tirzepatide options. TMates stands out for a flat $199/month pricing model that the company says holds at all doses and for 24/7 access to U.S.-based doctors across all 50 states.
Choose IVIM Health if…
you prioritize third-party satisfaction signals, want both semaglutide and tirzepatide compounded options, and value a clinician-guided optimization protocol with a free consultation and a promotional free month code.
Choose TMates if…
you want predictable flat monthly pricing with no step-up fees and 24/7 access to U.S.-based physicians across all states for ongoing questions and virtual check-ins.
Comparison keyword: IVIM Health vs TMates